Literature DB >> 16585305

Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less.

Josh Koch1, Gaynelle Hensley, Lonnie Roy, Shannon Brown, Claudio Ramaciotti, Charles R Rosenfeld.   

Abstract

OBJECTIVE: Ductus arteriosus (DA) closure occurs within 96 hours in >95% of neonates >1500 g in birth weight (BW). The prevalence and postnatal age of spontaneous ductal closure in neonates < or =1000 g in BW (extremely low birth weight [ELBW] neonates) remain unclear, as does the incidence of failure to close with indomethacin. Therefore, we prospectively examined the prevalence, postnatal age, and clinical variables associated with spontaneous DA closure, occurrence of persistent patent DA, and indomethacin failure in ELBW neonates.
METHODS: Neonates delivered at Parkland Memorial Hospital from February 2001 through December 2003 were studied. Those with congenital heart defects or death <10 days postnatally were excluded. Echocardiograms were performed 48 to 72 hours postnatal and every 48 hours until 10 days postnatally.
RESULTS: We studied 122 neonates with BW of 794 +/- 118 (SD) g and estimated gestational age (EGA) of 26 +/- 2 weeks. Spontaneous permanent DA closure occurred in 42 (34%) neonates at 4.3 +/- 2 days postnatally, with 100% closure by 8 days. These neonates were more mature, less likely to have received antenatal steroids or have hyaline membrane disease (HMD; 52% vs 79%), and more likely to be growth restricted (31% vs 5%) and delivered of hypertensive women. Using regression analysis, EGA and absence of antenatal steroids and HMD predicted ductal closure. Ten (8%) neonates with early DA closure reopened and required medical/surgical closure. Eighty neonates had persistent patent DA; 7 were surgically ligated, and 5 remained asymptomatic, with 4 of 5 closing after 10 days postnatally. Sixty-eight (85%) received indomethacin at 6.2 +/- 4 days postnatally; 41% failed therapy and had no distinguishing characteristics.
CONCLUSIONS: Spontaneous permanent DA closure occurs in >34% of ELBW neonates and is predicted by variables related to maturation, for example, EGA and an absence of HMD, whereas indomethacin failure could not be predicated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585305     DOI: 10.1542/peds.2005-1528

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  80 in total

1.  Functional Neonatal Echocardiography: Indian Experience.

Authors:  Anilkumar Mohan Khamkar; Pradeep B Suryawanshi; Rajesh Maheshwari; Suprabha Patnaik; Nandini Malshe; Vijay Kalrao; Sanjay Lalwani; Jitendra Surwade
Journal:  J Clin Diagn Res       Date:  2015-12-01

2.  The Patent Ductus Arteriosus Problem: Infants Who Still Need Treatment.

Authors:  Jeff Reese; Matthew M Laughon
Journal:  J Pediatr       Date:  2015-08-24       Impact factor: 4.406

3.  Diagnosis and Management of Patent Ductus Arteriosus.

Authors:  Maria Gillam-Krakauer; Jeff Reese
Journal:  Neoreviews       Date:  2018-07

4.  Conservative treatment for patent ductus arteriosus in the preterm.

Authors:  Sophie Vanhaesebrouck; Inge Zonnenberg; Piet Vandervoort; Els Bruneel; Marie-Rose Van Hoestenberghe; Claire Theyskens
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-01-09       Impact factor: 5.747

5.  Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome.

Authors:  Juliette C Madan; Douglas Kendrick; James I Hagadorn; Ivan D Frantz
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

6.  Comparative effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus.

Authors:  Brian C Gulack; Matthew M Laughon; Reese H Clark; Meera N Sankar; Christoph P Hornik; P Brian Smith
Journal:  Early Hum Dev       Date:  2015-09-19       Impact factor: 2.079

7.  Disorders in glucidic metabolism and congenital heart diseases: detection and prevention.

Authors:  G Passarella; G Trifirò; M Gasparetto; G Svaluto Moreolo; O Milanesi
Journal:  Pediatr Cardiol       Date:  2012-11-15       Impact factor: 1.655

8.  Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants.

Authors:  Chuan-Zhong Yang; Jiun Lee
Journal:  World J Pediatr       Date:  2008-05       Impact factor: 2.764

9.  Ibuprofen in very preterm infants impairs renal function for the first month of life.

Authors:  Rachel Vieux; Roxane Desandes; Farid Boubred; Denis Semama; Francis Guillemin; Marie-Christine Buchweiller; Jeanne Fresson; Jean-Michel Hascoet
Journal:  Pediatr Nephrol       Date:  2009-11-10       Impact factor: 3.714

10.  Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus.

Authors:  S S Khan; T Sithisarn; H S Bada; M Vranicar; P M Westgate; M Hanna
Journal:  J Perinatol       Date:  2017-09-14       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.